Clinicopathological and Prognostic Significance of PRMT5 in Cancers: A System Review and Meta-Analysis.
Clinicopathological and Prognostic Significance of PRMT5 in Cancers: A System Review and Meta-Analysis.
复制标题
PRMT5 在癌症中的临床病理学和预后意义：系统回顾和荟萃分析
DOI：
10.1177/10732748211050583
复制
发表时间：
2021-01
期刊：
影响因子：
--
通讯作者：
Liu X
中科院分区：
文献类型：
--
作者：
Liang Z;Liu L;Wen C;Jiang H;Ye T;Ma S;Liu X
Purpose Since protein arginine methyltransferase 5 (PRMT5) is abnormally expressed in various tumors, in this study we aim to assess the association between PRMT5 and clinicopathological and prognostic features. Methods Electronic databases including PubMed, Web of Science, Scopus, ScienceDirect, and the Cochrane Library were searched until July 25, 2021. The critical appraisal of the eligible studies was performed using the Newcastle–Ottawa Quality Assessment Scale. Pooled hazard ratios (HR) and pooled odds ratios (OR) were calculated to assess the effect. Engauge Digitizer version 12.1, STATA version 15.1, and R version 4.0.5 were used to obtain and analysis the data. Results A total of 32 original studies covering 15,583 patients were included. In our data, it indicated that high level of PRMT5 was significantly correlated with advanced tumor stage (OR = 2.12, 95% CI: 1.22-3.70, P =.008; I2 = 80.7%) and positively correlated with poor overall survival (HR = 1.59, 95% CI: 1.46-1.73, P < .001; I2 = 50%) and progression-free survival (HR = 1.53, 95% CI: 1.24-1.88, P < .001; I2 = 0%). In addition, sub-group analysis showed that high level of PRMT5 was associated with poor overall survival for such 5 kinds of cancers as hepatocellular carcinoma, pancreatic cancer, breast cancer, gastric cancer, and lung cancer. Conclusion For the first time we found PRMT5 was pan-cancerous as a prognostic biomarker and high level of PRMT5 was associated with poor prognosis for certain cancers.
登录
查看更多内容
含SET结构域的蛋白8和蛋白精氨酸甲基转移酶5对肝细胞癌根治性切除术后患者预后的影响
影响因子：
2.9
作者：
Lin Z;Jia H;Hong L;Zheng Y;Shao W;Ren X;Zhu W;Lu L;Lu M;Zhang J;Chen J
通讯作者：
Chen J
Snail/PRMT5/NuRD 复合物通过抑制 TET1 导致宫颈癌 DNA 高甲基化
影响因子：
12.4
作者：
Gao J;Liu R;Feng D;Huang W;Huo M;Zhang J;Leng S;Yang Y;Yang T;Yin X;Teng X;Yu H;Yuan B;Wang Y
通讯作者：
Wang Y
影响因子：
9.7
作者：
Jing, Pengyu;Zhao, Nan;Gu, Zhongping
通讯作者：
Gu, Zhongping
影响因子：
5.2
作者：
Kanda, Mitsuro;Shimizu, Dai;Kodera, Yasuhiro
通讯作者：
Kodera, Yasuhiro
影响因子：
5.3
作者：
Hou, Zhaoyuan;Peng, Hongzhuang;Rauscher, Frank J., III
通讯作者：
Rauscher, Frank J., III